Filing Details

Accession Number:
0000899243-23-005689
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-02-21 16:30:44
Reporting Period:
2022-08-16
Accepted Time:
2023-02-21 16:30:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1659352 Codiak Biosciences Inc. CDAK Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1828135 Nicole Barna C/O Codiak Biosciences, Inc.
35 Cambridgepark Drive, Suite 500
Cambridge MA 02140
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-08-16 3,150 $0.00 11,262 No 4 M Direct
Common Stock Disposition 2022-08-17 984 $2.21 10,278 No 4 S Direct
Common Stock Acquisiton 2023-02-16 3,150 $0.00 13,428 No 4 M Direct
Common Stock Disposition 2023-02-17 1,274 $0.59 12,154 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2022-08-16 3,150 $0.00 3,150 $0.00
Common Stock Restricted Stock Units Disposition 2023-02-16 3,150 $0.00 3,150 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
9,450 No 4 M Direct
6,300 No 4 M Direct
Footnotes
  1. Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
  2. The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of RSUs pursuant to a "sell to cover" provision included in the RSU Agreement.
  3. Each RSU represents a contingent right to receive one share of common stock.
  4. On February 16, 2022, the reporting person was granted 12,600 RSUs, vesting in four equal installments every six months beginning on the six month anniversary of the grant date.